-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 19, 2021, Guangzhou Lupeng Pharmaceutical Co.
LP-128 is an oral, potent and highly selective HBsAg inhibitor with completely independent intellectual property rights in the world
Dr.
LP-128 is the company's fourth innovative drug that has entered the clinical research stage after LP-108, LP-118, and LP-168.